InvestorsHub Logo
Followers 145
Posts 27556
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 7

Monday, 12/01/2014 9:15:31 AM

Monday, December 01, 2014 9:15:31 AM

Post# of 48
"We are pleased that this medical center selected the IOPtiMate™ system as its glaucoma surgery solution. This milestone conveys further confidence in our unique technology from the ophthalmology community and, along with our recent first sale in Hong Kong and our launch in China, demonstrates our ability to become a truly global player in this marketplace," said Suzana Nahum-Zilberberg, BioLight's chief executive officer.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.